Investment
Features
FeesSafety
Academy
More
Pluang+

A $99.8M Ether long position nears liquidation as ETH price drops to $2,501.38

Market News
07 Oct 2026
Tokenpost
View Source
Bearish
A $99.8M Ether long position nears liquidation as ETH price drops to $2,501.38

A large long position of 39,025 Ether, valued at about $99.8 million and held by Huang Licheng, is close to being liquidated due to a decline in the cryptocurrency market. The liquidation price is set at $2,501.38 per ETH, meaning if the price falls to this level, the position will be forcibly closed to prevent further losses. This highlights the risks of leveraged trading in volatile crypto markets, where falling prices can trigger forced liquidations.

Huang Licheng's large Ether long position nearing liquidation provides context for cryptocurrency market conditions. For readers following crypto, here is Pluang's market snapshot as of Oct 07, 2026 20:22 WIB: Of 50 major cryptocurrencies priced on Pluang, 6 rose and 43 fell today. Notable movers include UNI at Rp142.275 with a 1-day change of -10.32% and Pluang order activity of 35% Sell / 65% Buy, FIL at Rp18.964 down 8.78% with 56% Sell / 44% Buy, and DOT at Rp19.771 down 8.75% with 70% Sell / 30% Buy. Typical hold times range from 65 to 121 days.

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
50 minutes ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
54 minutes ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
1 hour ago
Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...

Analyst Insights
Bullish
2 hours ago
Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...

Analyst Insights
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App